Experts discuss the use of artificial intelligence (AI) and patient-centric strategies in oncology clinical trials.

Anal cancer is relatively uncommon, accounting for approximately 2.5% of all gastrointestinal cancers. Nonetheless, its ...

Several companies are advancing treatments for anal cancer, including Merck (KEYTRUDA), BioMimetix (BMX-001), Novartis (KFA115), and Bicara Therapeutics (BCA101), among others. As immunotherapy ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

In the assessment of 12-month price targets, analysts unveil insights for Intellia Therapeutics, presenting an average target ...

Metastatic breast cancer market is projected to grow significantly through 2035, driven by rising cases, treatment advances, and expanding R&D investments.

One provision stands out: the law’s “pill penalty.” The IRA doesn’t treat all medicines equally. “Small molecule” medicines, ...

The global sales of Small Molecule API are estimated to be worth USD 120.4 billion in 2024 and are anticipated to reach a value of USD 186.9 billion by 2034. Sales are projected to rise at a CAGR of 4 ...

Growth is driven by the aging population, rising chronic diseases, and self-administration practices. Advances in technology, new product launches, and favorable policies bolster growth. Injectable ...